SAN DIEGO, March 10, 2011 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, said today that it will be participating in the Roth 23rd Annual Orange County Growth Stock Conference on Monday, March 14.
The presentation by David Sheehan, President, IVUS and FM Business Units, will begin at 11:30 a.m., Pacific Daylight Time, (2:30 p.m., Eastern Daylight Time).
The presentation will be available through the conference website at http://www.wsw.com/webcast/roth24/volc/ and via the company’s website at www.volcanocorp.com.
Volcano Corporation is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Our products empower physicians around the world with a new generation of analytical tools that deliver more meaningful informationusing light and sound as the guiding elements. Founded in cardiovascular care and expanding into other specialties, Volcano is changing the assumption about what is possible in improving patient outcomes by combining imaging and therapy together. For more information, visit the company’s website at www.volcanocorp.com.
SOURCE Volcano Corporation
